Found: 19
Select item for more details and to access through your institution.
Identification of Two DNMT3A Mutations Compromising Protein Stability and Methylation Capacity in Acute Myeloid Leukemia.
- Published in:
- Journal of Oncology, 2019, p. 1, doi. 10.1155/2019/5985923
- By:
- Publication type:
- Article
The balance between mitotic death and mitotic slippage in acute leukemia: a new therapeutic window?
- Published in:
- Journal of Hematology & Oncology, 2019, v. 12, n. 1, p. N.PAG, doi. 10.1186/s13045-019-0808-4
- By:
- Publication type:
- Article
Targeting WEE1 to enhance conventional therapies for acute lymphoblastic leukemia.
- Published in:
- Journal of Hematology & Oncology, 2018, v. 11, n. 1, p. N.PAG, doi. 10.1186/s13045-018-0641-1
- By:
- Publication type:
- Article
Axitinib in Ponatinib-Resistant B-Cell Acute Lymphoblastic Leukemia Harboring a T315L Mutation.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 24, p. 9724, doi. 10.3390/ijms21249724
- By:
- Publication type:
- Article
Combined Oral Fentanyl Citrate and Midazolam as Premedication for Bone Marrow Aspiration and Biopsy in Patients with Hematological Malignancies: A Randomized, Controlled and Patient-Blinded Clinical Trial.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 2, p. 395, doi. 10.3390/jcm9020395
- By:
- Publication type:
- Article
Therapeutic Targeting of Acute Myeloid Leukemia by Gemtuzumab Ozogamicin.
- Published in:
- Cancers, 2021, v. 13, n. 18, p. 4566, doi. 10.3390/cancers13184566
- By:
- Publication type:
- Article
CART-Cell Therapy: Recent Advances and New Evidence in Multiple Myeloma.
- Published in:
- Cancers, 2021, v. 13, n. 11, p. 2639, doi. 10.3390/cancers13112639
- By:
- Publication type:
- Article
Synergism Through WEE1 and CHK1 Inhibition in Acute Lymphoblastic Leukemia.
- Published in:
- Cancers, 2019, v. 11, n. 11, p. 1654, doi. 10.3390/cancers11111654
- By:
- Publication type:
- Article
Targeting Proliferation Signals and the Cell Cycle Machinery in Acute Leukemias: Novel Molecules on the Horizon.
- Published in:
- Molecules, 2023, v. 28, n. 3, p. 1224, doi. 10.3390/molecules28031224
- By:
- Publication type:
- Article
Immunosuppressive Treg cells acquire the phenotype of effector-T cells in chronic lymphocytic leukemia patients.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Pharmacological Inhibition of WIP1 Sensitizes Acute Myeloid Leukemia Cells to the MDM2 Inhibitor Nutlin-3a.
- Published in:
- Biomedicines, 2021, v. 9, n. 4, p. 388, doi. 10.3390/biomedicines9040388
- By:
- Publication type:
- Article
In vitro and in vivo single-agent efficacy of checkpoint kinase inhibition in acute lymphoblastic leukemia.
- Published in:
- Journal of Hematology & Oncology, 2015, v. 8, p. 1, doi. 10.1186/s13045-015-0206-5
- By:
- Publication type:
- Article
Synthesis of Novel Tryptamine Derivatives and Their Biological Activity as Antitumor Agents.
- Published in:
- Molecules, 2021, v. 26, n. 3, p. 683, doi. 10.3390/molecules26030683
- By:
- Publication type:
- Article
CDC20 in and out of mitosis: a prognostic factor and therapeutic target in hematological malignancies.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2022, v. 41, n. 1, p. 1, doi. 10.1186/s13046-022-02363-9
- By:
- Publication type:
- Article
Targeting PARP proteins in acute leukemia: DNA damage response inhibition and therapeutic strategies.
- Published in:
- Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01228-0
- By:
- Publication type:
- Article
A WEE1 family business: regulation of mitosis, cancer progression, and therapeutic target.
- Published in:
- Journal of Hematology & Oncology, 2020, v. 13, n. 1, p. N.PAG, doi. 10.1186/s13045-020-00959-2
- By:
- Publication type:
- Article
ETV6::ABL1 -Positive Myeloid Neoplasm: A Case of a Durable Response to Imatinib Mesylate without Additional or Previous Treatment.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 1, p. 118, doi. 10.3390/ijms25010118
- By:
- Publication type:
- Article
Correction to: Exploring the ATR-CHK1 pathway in the response of doxorubicin-induced DNA damages in acute lymphoblastic leukemia cells.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Exploring the ATR-CHK1 pathway in the response of doxorubicin-induced DNA damages in acute lymphoblastic leukemia cells.
- Published in:
- Cell Biology & Toxicology, 2023, v. 39, n. 3, p. 795, doi. 10.1007/s10565-021-09640-x
- By:
- Publication type:
- Article